A 39-year-old woman with 3 prior episodes of aseptic meningitis without identified pathogen in cerebrospinal fluid (CSF) testing presented with 2 days of headache and neck stiffness. Examination was remarkable only for meningismus. Cerebrospinal fluid revealed lymphocytic pleocytosis (775 cells/mL, 82% lymphocytes, 13% monocytes), elevated total protein (90 mg/dL), normal glucose, negative Gram stain, and the presence of herpes simplex virus 2 (HSV-2) DNA on polymerase chain reaction (PCR) amplification. Cytology revealed large monocytes with varied nuclear morphologies, consistent with Mollaret cells (Figure 1 ). Treatment with intravenous acyclovir led to rapid clinical improvement.
Mollaret cells are activated monocytes with convoluted nuclear lobes and abundant cytoplasm with pseudopods that account for their typical "footprint" or "cloverleaf" shapes. Due to fragility of the nuclear and cytoplasmic membranes in vivo, 1 Mollaret cells are infrequently detected after 24 hours from symptom onset in recurrent benign lymphocytic meningitis attacks. 2 They are encountered in up to 90% of cases of recurrent benign lymphocytic meningitis, or "Mollaret meningitis," which is strongly linked to HSV-2 reactivation from latent virus in sacral sensory ganglia. 3 However, there are reports of Mollaret cells in meningitis secondary to other herpesviruses (eg, herpes simplex virus 1 (HSV-1), varicella zoster virus (VZV)) and West Nile Virus. 4 In addition to virologic testing, CSF should be reviewed for Mollaret cells when evaluating a case of recurrent aseptic meningitis.
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